Nanjing Leads Biolabs Co., Ltd. Class H

Nanjing Leads Biolabs Co., Ltd. Class H

HHKEX:9887
32.20
HKD
-1.06
(-3.19%)
-0.97EPS
Mar 29Next Earn

Important Dates

Nanjing Leads Biolabs Co., Ltd. Class H's next confirmed earnings release is scheduled for March 29, 2027.

Earnings Date3/29/2027

Share Statistics

As of June 30, 2025, Nanjing Leads Biolabs Co., Ltd. Class H has 188.55M shares outstanding.

Shares Outstanding188.55M

Financial Position

As of June 30, 2025, Nanjing Leads Biolabs Co., Ltd. Class H maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 285.64, indicating elevated leverage, while an interest coverage ratio of -42.98 demonstrates limited ability to service its debt obligations.

Current Ratio1.07
Quick Ratio0.88
Debt / Equity285.64
Debt / EBITDA-1.92
Interest Coverage-42.98

Stock Price Statistics

HKD

As of the close on November 17, 2026, Nanjing Leads Biolabs Co., Ltd. Class H's stock has declined approximately 44.48% over the past 52 weeks. The 50-day moving average sits at 45.98, while the 200-day moving average is 60.76.

52-Week Price Change-44.48%
50-Day Moving Average45.98
200-Day Moving Average60.76

Income Statement

HKD

Over the twelve months ended June 30, 2025, Nanjing Leads Biolabs Co., Ltd. Class H generated - - in revenue and converted that into -182.33M in net income, yielding earnings per share of -0.97. EBITDA reached -171.05M, while operating income came in at -183.51M.

Operating Income-183.51M
Pretax Income-182.33M
Net Income-182.33M
EBITDA-171.05M
EBIT-183.51M
Earnings Per Share (EPS)-0.97

Balance Sheet

HKD

As of June 30, 2025, Nanjing Leads Biolabs Co., Ltd. Class H holds 494.97M in cash and equivalents against 328.24M in total debt, resulting in a net debt position of -155.07M. Total book value stands at 114.91M, with working capital of 40.30M providing operational flexibility.

Cash & Cash Equivalents494.97M
Total Debt328.24M
Net Debt-155.07M
Equity (Book Value)114.91M
Book Value Per Share0.61
Working Capital40.30M

Cash Flow

HKD

Nanjing Leads Biolabs Co., Ltd. Class H produced -109.62M in operating cash flow over the twelve months ended June 30, 2025. After subtracting -1.95M in capital expenditures, free cash flow totaled -111.57M - equivalent to -0.59 per share.

Operating Cash Flow-109.62M
Capital Expenditures-1.95M
Free Cash Flow-111.57M
FCF Per Share-0.59